SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending due to positive news around its material verification technology, specifically its adoption in precious metals and recycling, sparking retail investor interest. The community is discussing the potential for a continued squeeze and high price targets, while acknowledging the stock's volatility and past reverse splits. Some traders caution about potential dilution and the risk of chasing the rally.

A beloved 9-year-old tabby cat, cherished mascot of Randa's Market, and the heart of the Mission District. KitKat was more than just a bodega cat—he was our neighborhood ambassador, our security guard, and everyone's best friend. On October 28, 2025, KitKat's life was tragically cut short when he was allegedly struck by a Waymo autonomous vehicle. The community is heartbroken. This token honors his memory and demands justice for all innocent lives.

Remember KitKat

KITKAT CRYPTO is trending amidst heavy community discussion regarding its value and purpose, with many expressing strong negative sentiment and accusing the developers of fee farming and botting the chart. Despite news coverage, the coin's price action is failing to impress investors, leading to frustration and bag-holding.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash is trending as unusual options activity and analyst upgrades spark bullish sentiment, with some community members eyeing potential short squeezes.  Discussions also highlight the company's growth in total orders and market reach through partnerships, although rising competition and valuation concerns remain talking points. Some traders are closely monitoring technical indicators for potential entry points, while others express concerns about the long-term sustainability of DoorDash's business model.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending due to community excitement around its potential as foundational infrastructure for TradFi, emphasized by its high throughput and compliance-aware design. Investors are actively discussing the token's value proposition in comparison to major platforms like Amazon, Google, and Microsoft, viewing KTA as a targeted bet on the future of financial plumbing. The community also highlights potential partnerships, particularly with Stripe, as a key catalyst.

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Coya Therapeutics Inc

COYA is trending amidst positive analyst ratings and upcoming data releases, particularly the Alzheimers study funded by the Gates Foundation. Community discussions focus on the potential for significant valuation increases and the strategic importance of COYA's Treg-targeted therapies in neurodegenerative diseases. Market participants are anticipating updates on the ALS trial, with some speculating about a potential acquisition by Dr. Reddys.

Copart, Inc. engages in the provision of online auctions and vehicle remarketing services. The firm offers vehicle sellers a full range of services to process and sell vehicles primarily over the internet through Virtual Bidding Third Generation Internet auction-style sales technology. It sells vehicles principally to licensed vehicle dismantlers, rebuilders, repair licensees, used vehicle dealers, exporters and at certain locations, and the public. The company’s services include online seller access, salvage estimation services, estimating services, end-of-life vehicle processing, virtual insured exchange, transportation services, vehicle inspection stations, on-demand reporting, DMV processing, and vehicle processing programs. It operates through the United States and International segments. The company was founded by Willis J. Johnson in 1982 and is headquartered in Dallas, TX.

Copart, Inc.

Copart is trending as investors discuss its competitive advantages, including high barriers to entry and network effects within the salvage/auction niche. Community members are analyzing the company's use of AI to improve efficiency and margins, with some suggesting the stock is poised to grind higher. Bullish sentiment is further fueled by discussions of potential catalysts such as margin expansion, international growth, and increased total loss frequency.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending amid community discussion surrounding the potential release of its Phase 3 HOPE-3 trial data for Duchenne Muscular Dystrophy, with speculation about an imminent announcement creating volatility. Community members are debating the likelihood of positive results, the impact on the stock price, and the validity of short reports questioning the therapy's efficacy. Bullish investors express confidence in the science and potential for a short squeeze, while bearish investors point to past failures and regulatory hurdles.

Dynex Capital, Inc. is an internally managed mortgage real estate investment trust. It engages in the business of investing in mortgage-backed securities. The company was founded on December 18, 1987 and is headquartered in Glen Allen, VA.

Dynex Capital, Inc.

Dynex Capital ($DX) is trending as investors focus on its attractive monthly dividend, with discussions around its sustainability and yield compared to peers. The community highlights Dynex's consistent dividend payments and solid management team, making it a popular choice for income-focused portfolios. Recent market volatility and broader REIT sector trends are also influencing conversations around the stock.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is trending amid discussions about a major collaboration with Bristol Myers Squibb to co-develop a cancer drug, BNT327, generating both excitement and skepticism within the community. While some view the $11 billion deal as validation of BioNTech's oncology pipeline and mRNA technology, others question the deal's long-term impact and potential downsides, especially with concerns rising again about the efficacy of the COVID-19 vaccine.

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

ARB crypto is trending as investors weigh its potential against competitors like Keeta ($KTA), focusing on Arbitrum's role in Ethereum scaling and real-world asset tokenization with Robinhood. Community discussion revolves around ARB's fundamentals, upcoming token unlocks, and its position as a leading Layer-2 solution, while some see Keeta as a complementary infrastructure play for institutional flows.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


bsportkim

Bsport